Skip to main content
. 2014 Jul;96(1):151–159. doi: 10.1189/jlb.5A1213-644R

Figure 4. HR1 and HR2 antagonists block MDSC-mediated Nb clearance.

Figure 4.

(A and B) Eggs/gm feces in Nb-infected ± MDSCs (M) on indicated days (D) and ± daily CT treatment (A) or every other day CIM treatment (B). (C) Day 14 analysis of total MDSCs. (D) Flow cytometric determination of liver monocytic or granulocytic populations. *P < 0.05; **P < 0.005; ***P < 0.0005. Mean ± sd; n ≥ 5 with two independent experiments.

HHS Vulnerability Disclosure